SAM
CTNM

Sectoral Asset Management’s Contineum Therapeutics CTNM Stock Holding History

Sectoral Asset Management’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.5M Sell
727,587
-73,200
-9% -$982K 7.87% 2
2025
Q4 		$9.15M Hold
800,787
– – 7.34% 2
2025
Q3 		$9.41M Hold
800,787
– – 5.81% 1
2025
Q2 		$3.18M Hold
800,787
– – 2.1% 5
2025
Q1 		$5.59M Hold
800,787
– – 4.35% 5
2024
Q4 		$11.7M Sell
800,787
-100
-0% -$1.58K 7.83% 2
2024
Q3 		$15.3M Hold
800,887
– – 9.05% 2
2024
Q2 		$14.1M Buy
+800,887
New +$12.9M 5.73% 3

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sectoral Asset Management's CTNM Position: Q1 2026 in Review

Sectoral Asset Management reduced its Contineum Therapeutics (CTNM) stake by 9.1% in Q1 2026, selling an estimated $982K and leaving 727,587 shares worth $9.5M. The position accounts for 7.87% of the portfolio, ranked #2.

Sectoral Asset Management first reported a position in CTNM in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.3M in Q3 2024. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Sectoral Asset Management held 727,587 shares of Contineum Therapeutics worth $9.5M as of Q1 2026.
  • Sectoral Asset Management sold 73,200 Contineum Therapeutics shares in Q1 2026, an estimated $982K.
  • Contineum Therapeutics made up 7.87% of Sectoral Asset Management's portfolio in Q1 2026, its #2 holding.
  • Sectoral Asset Management first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Sectoral Asset Management's Contineum Therapeutics position peaked at $15.3M in Q3 2024.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.